000 01197 a2200313 4500
005 20250514122402.0
264 0 _c19981101
008 199811s 0 0 eng d
022 _a0002-9211
024 7 _a10.1007/BF02290198
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDREILING, D A
245 0 0 _aInhibitory effect of new anticholinergics on the basal and secretin-stimulated pancreatic secretion in patients with and without pancreatic disease: therapeutic and theoretic implications.
_h[electronic resource]
260 _bThe American journal of digestive diseases
_cJul 1960
300 _a639-54 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCholinergic Antagonists
650 0 4 _aGastrointestinal Hormones
_xpharmacology
650 0 4 _aHormones
650 0 4 _aHumans
650 0 4 _aPancreas
_xpharmacology
650 0 4 _aPancreatic Diseases
650 0 4 _aPancreatic Juice
650 0 4 _aParasympatholytics
_xpharmacology
650 0 4 _aSecretin
700 1 _aJANOWITZ, H D
773 0 _tThe American journal of digestive diseases
_gvol. 5
_gp. 639-54
856 4 0 _uhttps://doi.org/10.1007/BF02290198
_zAvailable from publisher's website
999 _c13584438
_d13584438